Bigul

Sanofi India Ltd - 500674 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

The audited financial results of the Company for the quarter and year ended 31st December 2019 were approved by the Board of Directors of the Company at its meeting held on 25th February 2020 and published on 27th February 2020. Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed the disclosures of related party transactions for the half year ended 31st December 2019 in the format specified in the applicable accounting standards.
12-03-2020
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.
12-03-2020
Bigul

Sanofi India Ltd - 500674 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aberdeen Standard Investments (Asia) Ltd
06-03-2020
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the Notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal.
04-03-2020
Bigul

Double whammy: Power brands give Sanofi revenues and an edge over peers

One-time dividend of Rs 243 has given a leg up to sentiment
26-02-2020
Bigul

Sanofi India Ltd - 500674 - Fixes Book Closure for Dividends (Final Dividend & One-time Special Dividend) & AGM

Sanofi India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 21, 2020 to April 28, 2020 (both days inclusive) for the purpose of Payment of Final Dividend as well as one-time Special Dividend & Annual General Meeting (AGM) of the Company to be held on April 28, 2020.The final as well as one-time special dividend, if approved by the shareholders will be paid on or after May 05, 2020.
26-02-2020
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, Secretarial Compliance Report for the year ended 31st December 2019, issued by Mr. Makarand Joshi, Practicing Company Secretary of M/s. Makarand M. Joshi & Co. Company Secretaries.
25-02-2020
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, Secretarial Compliance Report for the year ended 31st December 2019, issued by Mr. Makarand Joshi, Practicing Company Secretary of M/s. Makarand M. Joshi & Co. Company Secretaries.
25-02-2020
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Director

As required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you on the following changes in the Board of Directors of the Company: 1. Dr. Shailesh Ayyangar informed the Company vide his letter dated 25th February 2020 that due to his retirement as an employee of Sanofi group, he would like step down as Director of the Company with effect from end of the day on 25th February 2020. 2. Mr. Thomas Rouckout informed the Company vide his letter dated 25th February 2020 that he has taken up a new role within Sanofi Group and would not be able to spend time on Sanofi business in India. Therefore, he would like to step down as Director of the Company with effect from the noting of his resignation by the Board. The Board noted these resignations at its meeting held today.
25-02-2020
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.
25-02-2020
Next Page
Close

Let's Open Free Demat Account